Using real world evidence to inform decision-making across the drug development lifecycle is contingent upon the availability of high-quality de-identified data. Only Privacy Analytics can provide risk-based solutions that utilize world-class expertise to provide quality data, scalability, automation and privacy protection.
RWE is Patient-Level Data
DOWNLOAD THE DATASHEET
Different types of patient data require greater privacy controls. Key to RWE efforts is balancing privacy protection and use.
DOWNLOAD THE WHITE PAPER
“With this system, we keep the quality of the data and bring timely and accurate data insights to the healthcare industry without having to put patient privacy at risk. The data is much richer than what we had access to before.”
Richard Borelli, Principal of Commercial Effectiveness Services,